Abstract: The invention relates to a water treatment system (1) for dialysis treatments, wherein the water treatment system (1) comprises a permeate circuit with a reverse osmosis system (RO) and at least one tap (ES1, 2 . . . N) for permeate, whereby the reverse osmosis system (RO) is fed by the reflux of the at least one tap (ES1, 2 . . . N) for dialysis treatments and/or a raw water inflow (RZ), whereby the water treatment system further comprises a heat exchanger (WT), whereby a primary circuit (PK) of the heat exchanger (WT) is connected with a buffer tank (PT) for storing thermal energy, whereby a second circuit (SK) of the heat exchanger (WT) is integrated into the permeate circuit, whereby heat is transferred in a controlled manner from the buffer tank (PT) via the heat exchanger (WT) to permeate in the permeate circuit.
Abstract: A medical apparatus, such as a dialysis machine (e.g. a hemodialysis machine or a peritoneal dialysis machine), includes a plurality of components, one or more sensors corresponding to the components and configured to detect signals, a display and a control unit. The control unit is configured to: receive signals from the one or more sensors, determine, from the signals, a status of the medical apparatus, and determine control commands for the display based on the determined status for status-dependent control of the display. The described apparatus improves the human-machine interface in terms of set-up time, operating time and freedom from errors. Depending upon the determined status, different status-specific menus may be illustrated on the display in order to assist the user when operating the apparatus or advise the user about any errors or subsequent steps.
Abstract: The present invention relates to a method for checking a dialyzer for the presence of a leak in the semipermeable membrane of the dialyzer, wherein the membrane divides the inner dialyzer space into a least one blood chamber and into at least one dialyzate chamber, wherein the blood chamber is flowed through by blood in the operation of the dialyzer and is in fluid communication with a blood-side line system and the vascular system of the patient, and wherein the dialyzate chamber is flowed through by dialysis fluid in the operation of the dialyzer and is in fluid communication with a dialyzate-side line system, wherein the method comprises the following steps: a) emptying the blood chamber or the dialyzate chamber of blood and of dialysis fluid respectively and keeping the fluid (blood or dialyzate) in the non-emptied dialyzate chamber or blood chamber; b) building up a test pressure by means of a gas, in particular by means of air, in the emptied blood chamber or in the emptied dialyzate chamber; and c)
Abstract: The invention relates to a method of determining a permeation property of hollow-fibre membranes wherein the permeation property of the hollow-fibre membrane is determined on a hollow-fibre membrane bundle which has been introduced into a housing and has terminally open hollow-fibre membranes at a first end of the hollow-fibre membrane bundle and terminally closed hollow-fibre membranes at a second end of the hollow-fibre membrane bundle. The invention more particularly relates to a method of determining the ultrafiltration rate and/or the ultrafiltration coefficient of hollow-fibre membranes.
Abstract: The invention relates to a multi-chamber bag 1 for medical purposes which is formed by films 2, 3, in particular flexible films, that are arranged against one another, are made of an at least partially transparent material and are interconnected in a liquid-tight manner using at least one non-separable seam 5, the bag being divided into at least two chambers 1A, 1B by at least one separable seam 8, by means of which the films arranged against one another are interconnected in a liquid-tight manner. The multi-chamber bag according to the invention is characterised by at least one visually perceptible structure 10 that signals the state of the at least one separable seam 8 and can be easily optically detected. Using this visible structure 10, the user can immediately identify whether the seam 8 is open or closed.
Type:
Application
Filed:
July 9, 2019
Publication date:
July 1, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Robert BERLICH, Jochen HUPPERT, Andreas LAUBROCK, Gerhard MAGER
Abstract: The invention relates to a composite material consisting of at least three constituents, a substrate material, a first fibrous reinforcing material and a second reinforcing material, wherein the first fibrous reinforcing material has a lower thermal expansion coefficient than the second reinforcing material and wherein the second reinforcing material has a lower electrical conductivity than the first reinforcing material, wherein the composite material is provided for use in building components of force and motion transmission, in particular those building components of force and motion transmission which come into contact with ultrapure water.
Type:
Application
Filed:
May 24, 2019
Publication date:
July 1, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Gerome FISCHER, Arne PETERS, Wolfgang KUNZ, Scott COHEN
Abstract: The invention relates to a method for potting hollow fiber membranes in potting compounds of increased temperature resistance, wherein an isocyanate component with inorganic particles and a polyol component are processed into a potting compound and the hollow fiber membranes are tightly encased by the potting compound in at least one potting zone by the hardening of said potting compound.
Type:
Application
Filed:
June 12, 2019
Publication date:
July 1, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Abstract: The present invention relates to an apparatus (1) for holding a disposable medical item, in particular a dialyzer (2), plasma filter or adsorbent, for treating blood, a system (10) comprising such an apparatus, and a method for operating a disposable medical item for treating blood. A bearing device (4) is thereby configured to rotatably support the disposable item, and a drive device (5) is thereby configured to rotate the rotatably mounted disposable item around a longitudinal axis (L) extending substantially in a direction in which the blood flows through the disposable item when the disposable item is in operation. Alternatively or additionally, a sensor device (6) is configured to detect a rotation of the rotatably mounted disposable item around at least one rotational axis (L, Q), in particular around the longitudinal axis (L) and/or around a transverse axis (Q) running perpendicular to the longitudinal axis (L) and output corresponding sensor data.
Type:
Application
Filed:
April 26, 2019
Publication date:
June 24, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Alexander SCHROERS, Sven Marten CZERWONKA, Robin PARTENFELDER, Alexander MOSDZINSKI, Lena Maria HAHN, Jan-Willem WALDE
Abstract: The present invention relates to an apparatus for performing an automated peritoneal dialysis treatment on a patient, the apparatus comprising: a first dialysis fluid port for receiving a first dialysis fluid having a first composition, which is determined by the concentrations of a set of first dialysis fluid constituents; a dialysis fluid line system connecting the first dialysis fluid port to a patient terminal; at least one dialysis fluid pump acting on the dialysis fluid line system and configured to convey the first dialysis fluid from the first dialysis fluid port to the patient terminal; and a control unit operably connected to the at least one pump; wherein the apparatus further comprises a second dialysis fluid port for receiving a second dialysis fluid having a second composition, which is determined by the concentrations of a set of second dialysis fluid constituents.
Type:
Application
Filed:
August 27, 2019
Publication date:
June 17, 2021
Applicant:
Fresenius Medical Care Deutschland GmbH
Abstract: A transport device is provided for transporting objects from work station to work station. A production facility for producing products is also described. The transport device has an object carrier on which a plurality of object carrier elements are arranged for placing down objects, and a drive unit for driving the object carrier. The object carrier can be moved in successive cycles such that the object carrier elements can be transported on a movement path from work station to work station. At least one object carrier element on the object carrier is displaceable relative to the object carrier in the movement path. The transport device has a dog element and a retaining element that are assigned to the object carrier element. The carrier element is carried along by the object carrier and moved from work station to work station or the carrier element remains at a work station.
Type:
Grant
Filed:
April 10, 2017
Date of Patent:
June 15, 2021
Assignee:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
John Heppe, Pascal Joachimsky, Franz Kugelmann
Abstract: The present invention relates to a method for removing a first fluid from a blood filter for the blood treatment of a patient and/or for removing blood from the blood filter after completing the blood treatment session. It further relates to a medical treatment apparatus having a control device with which a method for removing a first fluid from a blood filter is executable, a digital storage medium, and a computer program product.
Abstract: An external functional means comprises at least one housing body, at least one chamber integrated into the housing body for receiving medical fluids, at least one passage integrated into the housing body for receiving and/or conducting a medical fluid, and at least one valve means completely or partly integrated into the housing body for controlling or regulating a fluid flowing through the external functional means. The invention further specifies a blood treatment apparatus and methods which may be carried out by means of the external functional means of the invention and by means of the blood treatment apparatus, respectively.
Type:
Grant
Filed:
September 26, 2017
Date of Patent:
May 25, 2021
Assignee:
Fresenius Medical Care Deutschland GmbH
Inventors:
Soeren Gronau, Goetz Guenther, Juergen Haecker, Martin Lauer, Joachim Manke, Dejan Nikolic, Manfred Weis
Abstract: The present invention relates to a dialysis machine comprising a balancing system that has at least one balancing chamber for a volumetrically exact supply and removal of dialysis solution to and from a dialyzer fluidically connected to the balancing system in operation; a water inlet system connected to the balancing system for the supply of fresh dialysis liquid, with the water inlet system having an apparatus for degassing water that is connected to an air separator of the dialysis machine, with a first subsection of the air separator serving as a mixing chamber and being connectable to at least one concentrate source via at least one concentrate line and being in fluid communication with the balancing system via at least one dialysate line, wherein the filling volume of a balancing chamber corresponds to or exceeds the sum of the volume of the mixing chamber and the inner volume of the dialysate line.
Type:
Application
Filed:
April 2, 2019
Publication date:
May 20, 2021
Applicant:
Fresenius Medical Care Deutschland GmbH
Inventors:
Peter KLÖFFEL, Tilman STÄBLEIN, Andreas SYFONIOS, Dirk HÜMMER, Tobias IRRGANG, Benedict GLASER
Abstract: A container includes a dry concentrate designed such that the dry concentrate forms an acid liquid concentrate, or a part of an acid liquid concentrate, which is suitable for manufacturing a dialysis solution, on the dissolution of the dry concentrate in a liquid, preferably in water.
Type:
Grant
Filed:
June 25, 2018
Date of Patent:
May 18, 2021
Assignee:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Peter Kloeffel, Gerhard Wiesen, Francois D'Ayot, Philippe Laffey, Benoit Luaire
Abstract: The invention relates to a method of determining a permeation property of hollow-fibre membranes wherein the permeation property of the hollow-fibre membrane is determined on a hollow-fibre membrane bundle which has been introduced into a housing and has terminally open hollow-fibre membranes at a first end of the hollow-fibre membrane bundle and terminally closed hollow-fibre membranes at a second end of the hollow-fibre membrane bundle. The invention more particularly relates to a method of determining the clearance, more particularly the diffusive clearance of hollow-fibre membranes.
Abstract: The present invention relates to a device for identifying the connection status between a patient catheter and a cassette system having flexible tubing assembly, which is intended to be used in a dialysis machine, wherein the device comprises the cassette system having flexible tubing assembly and an electrical circuit, which is disposed on the cassette system having flexible tubing assembly as well as on the patient catheter, and wherein the device furthermore comprises a measuring device for measuring at least one electrical property of the electrical circuit, which depends on said connection status.
Type:
Application
Filed:
June 28, 2018
Publication date:
May 13, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Torsten HOCHREIN, Stefan SAAL, Frank HEDMANN
Abstract: The present invention relates to a pump system for generating a volume flow of dialysis solution in a dialysis machine, wherein the pump system comprises at least one piston pump whose piston cooperates with a working fluid that in turn exerts force on a conveying means, in particular on a membrane, wherein setting means are provided by which the conveying volume of the piston pump per piston stroke can be reduced, with the setting means comprising a position-variable mechanical piston stop to reduce the piston stroke and/or means to reduce the quantity of the working fluid and/or means to reduce the volume of the conveying chamber that cooperates with the conveying means and that contains the dialysis solution to be conveyed.
Type:
Application
Filed:
July 3, 2018
Publication date:
May 13, 2021
Applicant:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Frank HEDMANN, Sven SEBESTA, Torsten HOCHREIN
Abstract: The present invention relates to a dialysis machine that is configured to be equipped with an extracorporeal blood system comprising a dialysis solution system that is configured to be equipped with a dialyzer, wherein a mixing region, in particular a mixing chamber, is provided in which the fresh dialysis solution or a component thereof is located in the operation of the dialysis machine, with a concentrate line being in fluid communication with the mixing region, through which concentrate line concentrate can be conducted from a concentrate container into the mixing region, wherein at least two electrically conductive elements are arranged spaced apart from one another in or at the concentrate line or lines; that a measuring device is provided which is electrically connected to the conductive elements and which is configured to measure the conductance or a value correlated therewith between them; and that a control unit is provided which is configured to compare the measured value with a desired value, with
Type:
Application
Filed:
March 26, 2019
Publication date:
May 13, 2021
Applicant:
Fresenius Medical Care Deutschland GmbH
Inventors:
Tobias IRRGANG, Tilman STÄBLEIN, Alfred GAGEL, Peter KLÖFFEL
Abstract: The present invention relates to a method of monitoring the bicarbonate content and the sodium content of a dialysis solution, wherein the dialysis solution is prepared while adding a bicarbonate component and an acidic sodium component, and wherein the method comprises the following steps: a. adding the acidic sodium component and measuring the conductivity (LFist,Na); b. adding the bicarbonate component and measuring the increase in conductivity (?LFist,BiC) caused by adding the bicarbonate component; c. determining the increase in conductivity (?LFexp,Bic) expected due to the addition of the bicarbonate component; d. checking whether the measured increase in conductivity (?LFist,Bic) lies in an expected range of the increase in conductivity (?LFexp,Bic); e. determining the total conductivity (LFexp,D) expected after the addition of the bicarbonate component and of the acidic sodium component; f.
Type:
Grant
Filed:
August 3, 2017
Date of Patent:
May 11, 2021
Assignee:
Fresenius Medical Care Deutschland GmbH
Inventors:
Alfred Gagel, Tilman Stablein, Jochen Popp
Abstract: The present disclosure relates to an addition line for adding an infusion solution to a fluid, which flows in an extracorporeal blood circuit, wherein the addition line comprises a pressure release valve or a check valve. It further relates to an extracorporeal blood circuit, a blood treatment apparatus and a method using the addition line.